The effect of multidrug resistance modulator HZ08 on pharmacodynamics and pharmacokinetics of adriamycin in xenograft-nude mice-Reference-Cited by-同舟云学术

The effect of multidrug resistance modulator HZ08 on pharmacodynamics and pharmacokinetics of adriamycin in xenograft-nude mice

Published:2015-01 Issue: Volume:66 Page:109-117
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Zhang Yanyan,Feng Yidong,Darshika Kodithuwakku Nandani,Zhang Bo,Hu Yahui,Fang Weirong,Li Yunman,Huang Wenlong

Funder

National Nature Science Foundation of PR China

National Science and Technology Major Project

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference39 articles.

1. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis;Ambudkar;Proc. Natl. Acad. Sci. USA,1992

2. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives;Binkhathlan;Curr. Cancer Drug Targets,2013

3. Toxicologic and pharmacokinetic study of low doses of verapamil combined with doxorubicin;Candussio;Life Sci.,2002

4. HZ08, a great regulator to reverse multidrug resistance via cycle arrest and apoptosis sensitization in MCF-7/ADM;Cen;Eur. J. Pharmacol.,2010

5. Effects of the multidrug resistance modulator HZ08 on the apoptosis pathway in human chronic leukaemia cell line K562/A02;Cen;Arzneimittelforschung,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-channel Small Animal Drug Metabolism Real-Time Monitoring Fluorescence System;Molecular Imaging and Biology;2023-12-19

2. Theranostic Nanoprobe Mediated Simultaneous Monitoring and Inhibition of P-Glycoprotein Potentiating Multidrug-Resistant Cancer Therapy;Analytical Chemistry;2019-08-12

3. The efficacy of WGA modified daunorubicin anti-resistant liposomes in treatment of drug-resistant MCF-7 breast cancer;Journal of Drug Targeting;2017-03-09